Hip Innovation Study of Reverse Hip Replacement

Hip Innovation Technology Reverse Hip Implant

Hip Innovation Technology (HIT) received FDA Investigational Device Exemption (IDE) approval to initiate a pivotal clinical study to further evaluate the company's Reverse Hip Replacement System (Reverse HRS) for use in primary total hip arthroplasty (THA).

The clinical study objective is to evaluate the safety and effectiveness of the Reverse...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0